UK Drug Pricing & IP Targeted As US Gears Up For Post-Brexit Trade Deal Talks
Executive Summary
The US has published its final negotiating objectives for a post-Brexit trade deal with the UK, which include pushing for stronger IP protections and changes to UK processes for patient access to new drugs.
You may also be interested in...
UK-US Free Trade Deal Plans Disappoint Industry
The UK has published its negotiating mandate for talks on a free trade deal with the US. As expected, intellectual property protection figures prominently, but the life sciences industry sees little merit in the government’s approach. It also warns that the UK’s future relationship with the EU could lead to greater regulatory burdens and costs.
Industry ‘Disappointed’ By UK Plans For Free Trade Deal With US
The UK has published its negotiating mandate for talks on a free trade deal with the US. As expected, intellectual property protection figures prominently, but the life sciences industry sees little merit in the government’s approach. It also warns that the UK’s future relationship with the EU could lead to greater regulatory burdens and costs.
Scotland Wants NHS Protected From Post-Brexit Trade Deals
The Scottish National Party has put the NHS, EU membership and Scottish independence at the heart of its campaign as the UK prepares to vote in the 12 December general election.